Sanyi Capital

Sanyi Capital operates across seed, start-up, growth, and PIPE transactions, meaning it can write first checks into early-stage companies and later participate in public-market financings for listed entities. This multi-stage, cross-market mandate is unusual among mainland Chinese PE firms, which typically separate venture and PIPE activities into distinct fund families or avoid one side entirely.

Available public information points to a direct-deal orientation across the venture and PIPE strategies documented for the firm. There is no disclosed record of Sanyi Capital operating as a fund-of-funds or making LP commitments to external Chinese or global venture managers.

Based on the firm's disclosed strategy, Sanyi Capital focuses on enterprise software, AI/ML, digital health, and industrial technology. These sectors align with China's stated policy goals around indigenous innovation and advanced manufacturing, and sit within the broader technology ecosystem that has attracted the bulk of Chinese PE capital over the last decade.

Sanyi Capital's mandate covers early-stage (seed and start-up), growth equity, and PIPE transactions. The inclusion of PIPE deals alongside early-stage venture means the firm can provide growth capital to publicly traded Chinese tech companies, typically through discounted equity placements, in addition to private company financings.

Sanyi Capital is structured as an independent private equity firm, not a single-family office. The firm's asset manager classification and multi-stage mandate are consistent with a pooled-fund or separate-accounts model raising external capital, though the precise LP base has not been publicly disclosed.